Risk factors
NutriBand (NTRB) risk factors
Item 1A of every NutriBand Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2026 10-K risk factors23 risks12 dropped4 reworded
No new standalone risks were added, while 12 prior risks covering FDA, development, manufacturing, commercialization, distributors and shareholder matters were dropped.
Filed Apr 29, 2026 - FY2025 10-K risk factors35 risks
NutriBand is entirely dependent on developing and winning FDA approval for its lead abuse-deterrent fentanyl transdermal system. Operations face significant risks from FDA restructuring and tariff increases on foreign raw materials. The company has a history of ineffective internal controls and an SEC settlement regarding past disclosure issues.
Filed Apr 28, 2025